A Rapid Molecular Detection Tool for Toxigenic M1UK  Streptococcus pyogenes

Stephan Brouwer1, Swairindhree Das2, Andrew J Hayes3

  • 1Australian Infectious Diseases Research Centre and Institute for Molecular Bioscience.

PubMed
Abstract

Insights

A new real-time PCR assay effectively detects the emerging Streptococcus pyogenes M1UK strain, a global health threat. This tool aids surveillance of the M1UK clone, which is linked to scarlet fever outbreaks.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • The Streptococcus pyogenes M1global genotype is being replaced by the M1UK variant, posing a global health risk.
  • The M1UK variant has 27 single-nucleotide polymorphisms and increased speA superantigen expression compared to M1global.
  • Increased surveillance is necessary due to the emergence of the M1UK clone.

Purpose of the Study:

  • To develop a rapid detection method for M1UK strains.
  • To determine the emm (sub)type distribution of S. pyogenes clinical isolates.
  • To enhance surveillance of the M1UK clone.

Main Methods:

  • Development of an allele-specific real-time polymerase chain reaction (PCR) assay for M1UK detection.
  • Utilizing whole genome sequencing for emm (sub)type analysis.
  • Analysis of 51 S. pyogenes clinical isolates (9 invasive, 42 noninvasive).

Main Results:

  • Emm1 was the most common S. pyogenes serotype (n=11).
  • M1UK was the dominant emm1 genotype in both invasive (4/5) and noninvasive (3/6) isolates.
  • Whole genome sequencing confirmed the presence of Australian M1UK sublineages linked to scarlet fever in Asia.

Conclusions:

  • A reliable target for detecting the toxigenic M1UK strain has been established.
  • The study confirms the continued presence and circulation of M1UK strains in Queensland, Australia.
  • The developed assay is a valuable, cost-effective tool for enhancing M1UK clone surveillance in laboratories.